The Clinical Significance of JAK2V617F Mutational Status on Phenotypic Features in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

被引：0
|
作者：
Sahin, Ezgi [1 ]
Yonal-Hindilerden, Ipek [1 ]
Hindilerden, Fehmi [2 ]
Daglar-Aday, Aynur [3 ]
Nalcaci, Meliha [1 ]
机构：
[1] Istanbul Univ, Div Hematol, Dept Internal Med, Istanbul Med Fac, Istanbul, Turkey
[2] Univ Hlth Sci Bakirkoy Dr Sadi Konuk Training & R, Hematol Clin, Istanbul, Turkey
[3] Istanbul Univ, Div Med Genet, Dept Internal Med, Istanbul Med Fac, Istanbul, Turkey
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
JAK2V16F mutation; polycythemia vera; essential thrombocythemia; primary myelofibrosis; MPN;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-364
引用
收藏
页码：S337 / S338
页数：2
相关论文
共 50 条
  • [31] Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms
    Ueda, Koki
    Ikeda, Kazuhiko
    Ikezoe, Takayuki
    Harada-Shirado, Kayo
    Ogawa, Kazuei
    Hashimoto, Yuko
    Sano, Takahiro
    Ohkawara, Hiroshi
    Kimura, Satoshi
    Shichishima-Nakamura, Akiko
    Nakamura, Yuichi
    Shikama, Yayoi
    Mori, Tsutomu
    Mason, Philip J.
    Bessler, Monica
    Morishita, Soji
    Komatsu, Norio
    Shide, Kotaro
    Shimoda, Kazuya
    Koide, Shuhei
    Aoyama, Kazumasa
    Oshima, Motohiko
    Iwama, Atsushi
    Takeishi, Yasuchika
    BLOOD ADVANCES, 2017, 1 (15) : 1001 - 1015
  • [32] JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms
    Choi, Daniel C.
    Messali, Nassima
    Uda, Narasimha Rao
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Yabut, Maria Mia
    Lischer, Heidi E. L.
    Tokumori, Franco Castillo
    Erdos, Katie
    Lehmann, Thomas
    Sobas, Marta
    Rao, Tata Nageswara
    Scandura, Joseph M.
    LEUKEMIA, 2024, 38 (11) : 2487 - 2491
  • [33] JAK2-positive Philadelphia-negative myeloproliferative neoplasms
    Sharma, Anjali
    Buxi, Gurdeep
    Marwah, Sadhna
    Yadav, Rajbala
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (01) : 117 - 120
  • [34] The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
    Holmstrom, M. O.
    Hjortso, M. D.
    Ahmad, S. M.
    Met, O.
    Martinenaite, E.
    Riley, C.
    Straten, P.
    Svane, I. M.
    Hasselbalch, H. C.
    Andersen, M. H.
    LEUKEMIA, 2017, 31 (02) : 495 - 498
  • [35] Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders
    Stein, Brady L.
    Williams, Donna M.
    Wang, Nae-Yuh
    Rogers, Ophelia
    Isaacs, Mary Ann
    Pemmaraju, Naveen
    Spivak, Jerry L.
    Moliterno, Alison R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1090 - 1097
  • [36] JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease
    Li, Juan
    Kent, David G.
    Godfrey, Anna L.
    Manning, Harriet
    Nangalia, Jyoti
    Aziz, Athar
    Chen, Edwin
    Saeb-Parsy, Kourosh
    Fink, Juergen
    Sneade, Rachel
    Hamilton, Tina L.
    Pask, Dean C.
    Silber, Yvonne
    Zhao, Xiaodong
    Ghevaert, Cedric
    Liu, Pentao
    Green, Anthony R.
    BLOOD, 2014, 123 (20) : 3139 - 3151
  • [37] Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis
    De Moner, Blanca
    Martinez-Sanchez, Julia
    Garrote, Marta
    Ramos, Alex
    Ventosa-Capell, Helena
    Moreno-Castano, Ana
    Nomdedeu, Meritxell
    Ojeda, Asuncion
    Escolar, Gines
    Garcia-Pagan, Joan Carles
    Arellano-Rodrigo, Eduardo
    Carreras, Enric
    Alvarez-Larran, Alberto
    Diaz-Ricart, Maribel
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [38] Myeloproliferative disorders "Philadelphia negative" and JAK2V617F mutation: study of 15 cases in Togo
    Padaro, Essohana
    Agbetiafa, Kossi
    Kueviakoe, Irenee Messanh Delagnon
    Layibo, Yao
    Amegbor, Koffi
    Vovor, Ahoefa
    Giraudier, Stephane
    Sanogo, Ibrahima
    Segbena, Akuete Yvon
    ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (05) : 591 - 594
  • [39] JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms
    Payzin, Kadriye Bahriye
    Savasoglu, Kaan
    Alacacioglu, Inci
    Ozdemirkiran, Fusun
    Mutlu, Belgin Berber
    Bener, Sadi
    Calli, Aylin Orgen
    Kucukzeybek, Betul Bolat
    Aksun, Saliha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (06) : 525 - 533
  • [40] Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
    Holl, Kristin
    Chatain, Nicolas
    Krapp, Susanne
    Baumeister, Julian
    Maie, Tiago
    Schmitz, Sarah
    Scheufen, Anja
    Brock, Nathalie
    Koschmieder, Steffen
    Moreno-Andres, Daniel
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345